Vadodara-based Sudeep Pharma has filed preliminary papers with capital markets regulator Sebi to raise funds through an initial public offering (IPO).

Vadodara-based Sudeep Pharma files draft papers with SEBI for an IPO, aiming to raise funds through fresh issuance and offer ...

Fear of change is a key limiting factor that is slowing the adoption and value of AI across life sciences. It doesn't have to ...

The IPO comprises a fresh issue worth Rs 95 crore and an offer for sale (OFS) of up to 1,00,76,492 equity shares by the ...

As part of celebrating WWMT's 75th birthday, we're catching up with some of the people who have been part of television ...

From a valuation standpoint, Pfizer appears attractive relative to the industry and is trading below its 5-year mean. Going ...

According to a new comprehensive report from The Insight Partners, the global pulmonary drug delivery system market is ...

Near-term headwinds include reduced COVID vaccination rates, market share losses to competitors like Pfizer/BioNTech ...

AbbVie ABBV has built a substantial oncology franchise. Initially anchored by blood cancer drugs Imbruvica and Venclexta, the ...

Sudeep Pharma Limited has filed its draft red herring prospectus with SEBI for an IPO. Established in 1989, the company ...

Wilson Borough Council approved a tax abatement program for its portion of the land where a million-square-foot warehouse is proposed near Route 22.